13F Data
13F filer · CIK 1931118

SUPERSTRING CAPITAL MANAGEMENT LP

NEW YORK, NY · filing since Q4 2023 · last filing Aug 14, 2026
Reported value
$158.4M
+$18.4M vs prior
Positions
32
New / sold out
8 / 11
Added / reduced
13 / 9
Turnover
40.6%
buys $60.6M · sells $76.3M
Top-10 weight
63.8%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedAXSOME THERAPEUTICS INC.+42,699+380.7%+$10.5M
NewREVOLUTION MEDICINES INC+51,053–+$9.6M
AddedGENMAB A/S+233,891+118.9%+$6.4M
AddedTREVI THERAPEUTICS INC+272,658+108.4%+$5.1M
AddedCOGENT BIOSCIENCES INC+118,126+52.5%+$4.6M
AddedCLIMB BIO INC+321,873+161.6%+$4.2M
AddedCELLDEX THERAPEUTICS INC NEW+107,535+59.7%+$4.0M
NewBEONE MEDICINES LTD+12,273–+$3.5M
AddedORIC PHARMACEUTICALS INC+290,843+252.4%+$3.1M
AddedADLAI NORTYE LTD+137,649+33.2%+$1.6M
11 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outSUMMIT THERAPEUTICS INC-892,873-100.0%$-16.9M
ReducedDEFINIUM THERAPEUTICS INC-163,179-46.4%$-7.7M
ReducedUROGEN PHARMA LTD-196,058-50.6%$-7.2M
ReducedIMMUNOVANT INC-149,238-41.7%$-5.8M
Sold outVERTEX PHARMACEUTICALS INC-11,010-100.0%$-4.9M
Sold outIQVIA HLDGS INC-25,668-100.0%$-4.4M
ReducedSAVARA INC-608,517-38.4%$-3.7M
ReducedSIONNA THERAPEUTICS INC-77,868-55.2%$-3.4M
Sold outARVINAS INC-312,620-100.0%$-3.3M
Sold outORUKA THERAPEUTICS INC-63,591-100.0%$-3.1M
10 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2023: $140.1MQ1 2024: $151.2MQ2 2024: $79.3MQ3 2024: $114.2MQ4 2024: $115.5MQ1 2025: $84.0MQ2 2025: $84.5MQ3 2025: $101.5MQ4 2025: $186.8MQ1 2026: $140.0MQ2 2026: $158.4M
Q4 2023Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1COGENT BIOSCIENCES INCCOM343,284$13.3M8.39%
2AXSOME THERAPEUTICS INC.COM53,916$13.2M8.33%
3GENMAB A/SSPONSORED ADS430,600$11.8M7.47%
4CELLDEX THERAPEUTICS INC NEWCOM NEW287,583$10.7M6.76%
5TREVI THERAPEUTICS INCCOM524,224$9.8M6.17%
6REVOLUTION MEDICINES INCCOM51,053$9.6M6.04%
7DEFINIUM THERAPEUTICS INCCOM SHS188,282$8.9M5.59%
8VIR BIOTECHNOLOGY INCCOM853,685$8.7M5.49%
9IMMUNOVANT INCCOM208,368$8.0M5.07%
10UROGEN PHARMA LTDCOM191,313$7.0M4.45%
22 more rows. Subscribe for $29/month to see every row, download the data and use the API.